NCT06843590Phase 2Active not recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Study sponsor: Alkermes, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-11Estimated
Enrollment · participants126Estimated
Source updated2026-09-25Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status

Recorded edit
− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source

· 2 fields changed

Enrollment · participant count

Recorded edit
− Previous value

count: 96; type: ESTIMATED

+ Updated value

count: 126; type: ESTIMATED

Primary completion date

Recorded edit
− Previous value

2026-06

+ Updated value

2026-11

Check registry source